A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis

Journal of Clinical Psychopharmacology

Volumn 30, Issue 1, 2010, Pages 64-67

  Cassidy, Clifford M ^a   Rabinovitch, Mark ^a   Schmitz, Norbert ^a   Joober, Ridha ^a   Malla, Ashok ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Adherence; Antipsychotic medication; Clinical response; First episode psychosis; Measurement

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST EPISODE PSYCHOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEGATIVE SYNDROME; PATIENT COMPLIANCE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SELF ADMINISTRATION;

EID: 74549212555     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181ca03df     Document Type: Article

References (15)

1. Rabinovitch M, Bechard-Evans L, Schmitz N, et al. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry. 2009;54:28-35.
2. Kampman O, Laippala P, Vaananen J, et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002;110:39-48.
3. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106:286-290.
4. Malla A, Norman R, Schmitz N, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med. 2006;36:649-658.
5. Byerly M, Fisher R, Whatley K, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005;133:129-133.
6. Velligan DI, Wang M, Diamond P, et al. Relationships among subjective and objective measures of adherence to antipsychotic medications. Psychiatr Serv. 2007;58:1187-1192.
7. Velligan DI, Lam YW, Glahn DC, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull. 2006;32:724-742.
8. Kane JM, Eerdekens M, Lindenmayer JP, et al. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am J Psychiatry. 2003;160:1125-1132.
9. Nakonezny PA, Byerly MJ, Rush AJ. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity. Psychiatry Res. 2008;157:259-263.
10. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
11. Malla A, Norman R, McLean T, et al. A Canadian programme for early intervention in non-affective psychotic disorders. Aust N Z J Psychiatry. 2003;37:407-413.
12. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
13. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders. Washington: APA; 1997.
14. Meng X, Rosenthal R, Rubin DB. Comparing correlated correlation coefficients. Psychol Bull. 1992;111:172-175.
15. Bertelsen M, Jeppesen P, Petersen L, et al. Course of illness in a sample of 265 patients with first-episode psychosisVfive-year follow-up of the Danish OPUS trial. Schizophr Res. 2009;107:173-178.